Treatment of acute gonococcal conjunctivitis.
Because of the remarkable increasing incidence of gonorrhea, there is danger that gonococcal conjunctivitis also will increase. The ability of the gonococcus to rapidly cause corneal destruction and become increasingly resistant to penicillin make it imperative for ophthalmologists to keep up to date on effective treatment methods. A treatment schedule for acute gonococcal conjunctivitis is presented.
D000293:Adolescent; D000328:Adult; D002701:Chloramphenicol / Q000627:therapeutic use; D003231:Conjunctivitis / Q000188:drug therapy / Q000209:etiology*; D003320:Corneal Ulcer / Q000209:etiology; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006069:Gonorrhea / Q000188:drug therapy; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D009878:Ophthalmia Neonatorum / Q000209:etiology; D010402:Penicillin G Procaine / Q000627:therapeutic use; D011339:Probenecid / Q000627:therapeutic use; D013754:Tetracyclines / Q000627:therapeutic use
D013754:Tetracyclines; D010402:Penicillin G Procaine; D002701:Chloramphenicol; D011339:Probenecid